EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Peroral Endoscopic Cardial Constriction with Band Ligation for Gastroesophageal Reflux Disease: A Prospective Pilot Study

Satyam Kumar Singh, Ankit Agarwal, Chhagan Lal Birda iD, Shubham Kashyap, Kartikeya Mathur, Ashish Agarwal iD

Endoscopy International Open · 01.09.2026 · 14 (CP)

DOI: 10.1055/a-2938-5492 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy International Open, erschienen am 01.09.2026. Verfasst von Satyam Kumar Singh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of GastroenterologyAll India Institute of Medical Sciences JodhpurJodhpurRajasthanIndia. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Limited retrospective data suggest peroral endoscopic cardial constriction with band ligation (PECC-b) as a feasible, safe, and effective treatment for GERD. We performed a prospective study to assess the efficacy and safety of PECC-b for the treatment of GERD.

Methods

We prospectively recruited proton pump inhibitor (PPI)-dependent GERD patients. Patients with absence of acid reflux on a 24-hour pH study, esophageal motility disorder, and ≥Hill’s grade III hiatus on endoscopy were excluded. The primary endpoint was GERD health-related quality of life (GERD-HRQL) score improvement at 3 months. Secondary end points were decrease in PPI use, esophageal acid exposure time, reflux episodes, and DeMeester score at 3 months. Safety outcomes included serious and overall adverse events.

Results

Between July 2023 and June 2025, 130 patients were screened. Of these, 40 patients underwent PECC-b therapy (median age 34 years (IQR: 18–60), 75% male) and were followed up for 3 months. At follow-up, significant improvement in GERD-HRQL scores (22.8 ± 3.2 at baseline to 12 ± 4.7; p < 0.001) was observed. In total, 85% (n = 34) of the patients achieved complete or partial PPI independence at 3 months. Median acid exposure time decreased from 28.1% (IQR: 18.2–54.5%) to 14.8% (8.0–18.0%) (p < 0.05), median number of reflux episodes from 81.5 (53.8–126) to 30 (21.8–70.8) (p < 0.005), and the Demeester score decreased from 103 (51–161) to 52.5(33.5–78.3) (p < 0.005). Totally, 15 (37%) patients had chest pain postprocedure and required analgesics. There were no serious procedure-related adverse events.

Conclusion

PECC-b is a promising, safe, and effective endoscopic treatment for PPI-dependent GERD, offering significant symptomatic relief and improvement in quality of life.

Schlagwörter

Stichwörter der Autor:innen

GERDGERD-HRQLPECC-bPPIquality of life

Autor:innen und Institutionen

  • Department of GastroenterologyAll India Institute of Medical Sciences JodhpurJodhpurRajasthanIndia.

ORCID-Profile: Chhagan Lal Birda, Ashish Agarwal

Zitieren

APA

Singh, S. K., Agarwal, A., Birda, C. L., Kashyap, S., Mathur, K., & Agarwal, A. (2026). Peroral Endoscopic Cardial Constriction with Band Ligation for Gastroesophageal Reflux Disease: A Prospective Pilot Study. Endoscopy International Open, 14(CP). https://doi.org/10.1055/a-2938-5492

Vancouver

Singh SK, Agarwal A, Birda CL, Kashyap S, Mathur K, Agarwal A. Peroral Endoscopic Cardial Constriction with Band Ligation for Gastroesophageal Reflux Disease: A Prospective Pilot Study. Endoscopy International Open. 2026;14(CP). doi:10.1055/a-2938-5492

BibTeX
@article{Singh2026,
  author = {Singh, Satyam Kumar and Agarwal, Ankit and Birda, Chhagan Lal and Kashyap, Shubham and Mathur, Kartikeya and Agarwal, Ashish},
  title = {Peroral Endoscopic Cardial Constriction with Band Ligation for Gastroesophageal Reflux Disease: A Prospective Pilot Study},
  journal = {Endoscopy International Open},
  year = {2026},
  volume = {14},
  number = {CP},
  doi = {10.1055/a-2938-5492}
}
Kostenlos starten →